{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T02:53:21Z","timestamp":1760237601419,"version":"build-2065373602"},"reference-count":27,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2020,5,28]],"date-time":"2020-05-28T00:00:00Z","timestamp":1590624000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004694","name":"Kaohsiung medical university","doi-asserted-by":"publisher","award":["KMU-M108011"],"award-info":[{"award-number":["KMU-M108011"]}],"id":[{"id":"10.13039\/501100004694","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Taitung Mackay Memorial Hospital","award":["TTMMH-106-03"],"award-info":[{"award-number":["TTMMH-106-03"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and objectives: Recent randomized trials of oral antithrombotic drugs with atrial flutter (AFL) excluded patients with renal impairment because of their increased risk of bleeding. To date, no relevant studies have assessed the effectiveness and safety of different antithrombotic drugs in chronic kidney disease (CKD) patients with AFL. This cohort study evaluated the effectiveness and safety of different antithrombotic drugs in CKD patients with AFL. This study also investigated the risk of cardiovascular events from antithrombotic drugs through different risk profiles of stroke stratified by the CHA2DS2-VASc score. Materials and Methods: This cohort study was performed in patients with AFL and CKD who were extracted from the National Health Insurance (NHI) Database in Taiwan. Oral antithrombotic therapy (oral anticoagulants (OAC) or antiplatelets (APT)) was administered to patients who had been diagnosed with AFL after being diagnosed with CKD between 2011 and 2015. Primary outcomes, including ischemic stroke, systemic embolism, and composite of stroke, and secondary outcomes, including major adverse cardiac events (MACEs), major bleeding, all-cause mortality, and cardiovascular-related death, were examined. Results: A total of 2468 patients were included in this study. The results showed no statistically significant differences in the risk of primary outcomes. For the secondary outcomes, there were also no statistically significant differences in the risk of MACEs and major bleeding. However, the pooled results indicated that the hazard ratio (HR) for all-cause mortality with OAC was 0.24 (95% confidence interval (CI) = 0.10\u20130.55) compared with combination therapy, and the HR for APT compared with OAC was 2.86 (95% CI = 1.48\u20135.53). Conclusions: In the studied population, OAC or APT alone were proved equally effective for stroke prophylaxis. Furthermore, OAC might reduce the all-cause mortality rate compared with APT and should be considered as the first choice of oral antithrombotic drugs in patients with AFL and CKD.<\/jats:p>","DOI":"10.3390\/medicina56060266","type":"journal-article","created":{"date-parts":[[2020,5,28]],"date-time":"2020-05-28T08:27:48Z","timestamp":1590654468000},"page":"266","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Evaluating Effectiveness and Safety in Chronic Kidney Disease with Atrial Flutter Using an Anticoagulation Strategy"],"prefix":"10.3390","volume":"56","author":[{"given":"Ying-Ting","family":"Wang","sequence":"first","affiliation":[{"name":"Master Program in Clinical Pharmacy, School of Pharmacy, Kaohsiung Medical University, Kaohsiung 80708, Taiwan"},{"name":"Department of Pharmacy, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung 833, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7206-3957","authenticated-orcid":false,"given":"Chung-Yu","family":"Chen","sequence":"additional","affiliation":[{"name":"Master Program in Clinical Pharmacy, School of Pharmacy, Kaohsiung Medical University, Kaohsiung 80708, Taiwan"},{"name":"Department of Pharmacy, Kaohsiung Medical University Hospital, Kaohsiung 80708, Taiwan"},{"name":"Department of Medical Research, Kaohsiung Medical University Hospital, Kaohsiung 80708, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-Jong","family":"Bair","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Department of Internal Medicine, Taitung MacKay Memorial Hospital, Taitung 95054, Taiwan"},{"name":"MacKay Medical College, New Taipei City 252, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2020,5,28]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1440-1797.2010.01304.x","article-title":"Epidemiology, impact and preventive care of chronic kidney disease in Taiwan","volume":"15","author":"Hwang","year":"2010","journal-title":"Nephrology"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1016\/S0140-6736(08)60952-6","article-title":"All-cause mortality attributable to chronic kidney disease: A prospective cohort study based on 462 293 adults in Taiwan","volume":"371","author":"Wen","year":"2008","journal-title":"Lancet"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1161\/STROKEAHA.113.000883","article-title":"Risk of stroke or systemic embolism in atrial fibrillation patients treated with warfarin: A Systematic review and meta-analysis","volume":"44","author":"Albertsen","year":"2013","journal-title":"Stroke"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1056\/NEJMoa1105594","article-title":"Stroke and bleeding in atrial fibrillation with chronic kidney disease","volume":"367","author":"Olesen","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"ref_5","first-page":"287","article-title":"Oral anticoagulation in chronic kidney disease and atrial fibrillation","volume":"115","author":"Heine","year":"2018","journal-title":"Dtsch. Arztebl. Int."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.jstrokecerebrovasdis.2017.10.025","article-title":"Comparative risks of ischemic stroke in atrial flutter versus atrial fibrillation","volume":"27","author":"Omran","year":"2018","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1093\/europace\/euy181","article-title":"Clinical outcomes of solitary atrial flutter patients using anticoagulation therapy: A national cohort study","volume":"21","author":"Chen","year":"2019","journal-title":"Europace"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"331","DOI":"10.5603\/KP.a2013.0286","article-title":"Aspirin resistance in patients with impaired renal functions","volume":"72","author":"Aksu","year":"2014","journal-title":"Kardiol. Pol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1023\/A:1018758308979","article-title":"A pharmacodynamic study of clopidogrel in chronic hemodialysis patients","volume":"10","author":"Kaufman","year":"2000","journal-title":"J. Thromb. Thrombolysis"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"636","DOI":"10.5301\/JN.2011.6259","article-title":"Aspirin resistance in patients with chronic renal failure","volume":"24","author":"Tanrikulu","year":"2011","journal-title":"J. Nephrol."},{"key":"ref_11","first-page":"2674","article-title":"Effects of chronic kidney disease on platelet response to antiplatelet therapy in acute myocardial infarction patients","volume":"92","author":"Deng","year":"2012","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1681\/ASN.2010020220","article-title":"Low responsiveness to clopidogrel increases risk among CKD patients undergoing coronary intervention","volume":"22","author":"Htun","year":"2011","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"h246","DOI":"10.1136\/bmj.h246","article-title":"The association between kidney function and major bleeding in older adults with atrial fibrillation starting warfarin treatment: Population based observational study","volume":"350","author":"Jun","year":"2015","journal-title":"BMJ"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1001\/archinte.167.2.117","article-title":"Combined aspirin\u2013oral anticoagulant therapy compared with oral anticoagulant therapy alone among patients at risk for cardiovascular disease","volume":"167","author":"Dentali","year":"2007","journal-title":"Arch. Intern. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.ahj.2006.06.024","article-title":"Risks and benefits of combining aspirin with anticoagulant therapy in patients with atrial fibrillation: An exploratory analysis of stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) trials","volume":"152","author":"Flaker","year":"2006","journal-title":"Am. Heart J."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1161\/CIRCULATIONAHA.113.004834","article-title":"Antiplatelet therapy for stable coronary artery disease in atrial fibrillation patients taking an oral anticoagulant: A nationwide cohort study","volume":"129","author":"Lamberts","year":"2014","journal-title":"Circulation"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1161\/CIRCULATIONAHA.113.002927","article-title":"Use and associated risks of concomitant aspirin therapy with oral anticoagulation in patients with atrial fibrillation: Insights from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) Registry","volume":"128","author":"Steinberg","year":"2013","journal-title":"Circulation"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.recesp.2017.06.013","article-title":"Dual versus single antiplatelet regimen with or without anticoagulation in transcatheter aortic valve replacement: Indirect comparison and meta-analysis","volume":"71","author":"Verdoia","year":"2018","journal-title":"Rev. Esp. Cardiol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1161\/CIRCULATIONAHA.113.003187","article-title":"Early dual versus mono antiplatelet therapy for acute non-cardioembolic ischemic stroke or transient ischemic attack: An updated systematic review and meta-analysis","volume":"128","author":"Wong","year":"2013","journal-title":"Circulation"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1001\/archinternmed.2010.271","article-title":"Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation","volume":"170","author":"Hansen","year":"2010","journal-title":"Arch. Intern. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1016\/j.jacc.2014.07.957","article-title":"Incidence, source, determinants, and prognostic impact of major bleeding in outpatients with stable coronary artery disease","volume":"64","author":"Hamon","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"e180941","DOI":"10.1001\/jamanetworkopen.2018.0941","article-title":"Comparison of clinical outcomes among patients with atrial fibrillation or atrial flutter stratified by CHA2DS2-VASc Score","volume":"1","author":"Lin","year":"2018","journal-title":"JAMA Netw. Open"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1161\/01.CIR.0000145172.55640.93","article-title":"Selecting patients with atrial fibrillation for anticoagulation","volume":"110","author":"Gage","year":"2004","journal-title":"Circulation"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1002\/ccd.26653","article-title":"Short-versus long-term dual antiplatelet therapy after drug-eluting stent implantation in women versus men: A sex-specific patient-level pooled-analysis of six randomized trials","volume":"89","author":"Sawaya","year":"2016","journal-title":"Catheter. Cardiovasc. Interv."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.amjmed.2018.03.024","article-title":"Gender differences in antithrombotic treatment for newly diagnosed atrial fibrillation: The GLORIA-AF registry program","volume":"131","author":"Mazurek","year":"2018","journal-title":"Am. J. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1080\/14740338.2018.1524869","article-title":"Gender differences on benefits and risks associated with oral antithrombotic medications for coronary artery disease","volume":"17","author":"Romano","year":"2018","journal-title":"Expert Opin. Drug Saf."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"3754","DOI":"10.1161\/STR.0000000000000046","article-title":"Guidelines for the primary prevention of stroke","volume":"45","author":"Meschia","year":"2014","journal-title":"Stroke"}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/56\/6\/266\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T09:33:31Z","timestamp":1760175211000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/56\/6\/266"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,28]]},"references-count":27,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2020,6]]}},"alternative-id":["medicina56060266"],"URL":"https:\/\/doi.org\/10.3390\/medicina56060266","relation":{},"ISSN":["1648-9144"],"issn-type":[{"type":"electronic","value":"1648-9144"}],"subject":[],"published":{"date-parts":[[2020,5,28]]}}}